BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30143031)

  • 21. Effectiveness of radiofrequency ablation therapy for patients with unresected Stage IA non-small cell lung cancer.
    Li M; Qin Y; Mei A; Wang C; Fan L
    J Cancer Res Ther; 2020 Sep; 16(5):1007-1013. PubMed ID: 33004741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublobar Resection, Radiofrequency Ablation or Radiotherapy in Stage I Non-Small Cell Lung Cancer.
    Safi S; Rauch G; op den Winkel J; Kunz J; Schneider T; Bischof M; Heussel CP; Huber PE; Herth FJ; Dienemann H; Hoffmann H
    Respiration; 2015; 89(6):550-7. PubMed ID: 25968471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study.
    Ambrogi MC; Fanucchi O; Cioni R; Dini P; De Liperi A; Cappelli C; Davini F; Bartolozzi C; Mussi A
    J Thorac Oncol; 2011 Dec; 6(12):2044-51. PubMed ID: 22052222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
    Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.
    Pennathur A; Luketich JD; Abbas G; Chen M; Fernando HC; Gooding WE; Schuchert MJ; Gilbert S; Christie NA; Landreneau RJ
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):857-64. PubMed ID: 17903496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorodeoxyglucose positron emission tomography for detection of tumor recurrence following radiofrequency ablation in retrospective cohort of stage I lung cancer.
    Wang Y; Lanuti M; Bernheim A; Shepard JO; Sharma A
    Int J Hyperthermia; 2018; 35(1):1-8. PubMed ID: 29719997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?
    Kozower BD; Meyers BF; Reed CE; Jones DR; Decker PA; Putnam JB
    Ann Thorac Surg; 2008 Apr; 85(4):1166-9; discussion 1169-70. PubMed ID: 18355490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of PTC and RFA as treatment alternatives with low procedural morbidity in non-small cell lung cancer.
    Choe YH; Kim SR; Lee KS; Lee KY; Park SJ; Jin GY; Lee YC
    Eur J Cancer; 2009 Jul; 45(10):1773-9. PubMed ID: 19285385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency ablation of non-small-cell carcinoma of the lung under real-time FDG PET CT guidance.
    Schoellnast H; Larson SM; Nehmeh SA; Carrasquillo JA; Thornton RH; Solomon SB
    Cardiovasc Intervent Radiol; 2011 Feb; 34 Suppl 2():S182-5. PubMed ID: 20508937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous radiofrequency ablation for patients with malignant lung tumors: a phase II prospective multicenter study (JIVROSG-0702).
    Gobara H; Arai Y; Kobayashi T; Yamakado K; Inaba Y; Kodama Y; Yamagami T; Sone M; Watanabe H; Okumura Y; Shinya T; Kurihara H; Kanazawa S
    Jpn J Radiol; 2016 Aug; 34(8):556-63. PubMed ID: 27260478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
    Alafate A; Shinya T; Okumura Y; Sato S; Hiraki T; Ishii H; Gobara H; Kato K; Fujiwara T; Miyoshi S; Kaji M; Kanazawa S
    Acta Med Okayama; 2013; 67(2):105-12. PubMed ID: 23603927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.
    Zemlyak A; Moore WH; Bilfinger TV
    J Am Coll Surg; 2010 Jul; 211(1):68-72. PubMed ID: 20610251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
    Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer.
    Kim SR; Han HJ; Park SJ; Min KH; Lee MH; Chung CR; Kim MH; Jin GY; Lee YC
    Eur J Radiol; 2012 Feb; 81(2):395-9. PubMed ID: 21310562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radiofrequency ablation for lung neoplasms with isolated postsurgical local 
recurrences or metastases of non-small cell lung cancer].
    Liu B; Liu L; Hu M; Qian K; Li Y; Zhi X
    Zhongguo Fei Ai Za Zhi; 2014 Jun; 17(6):460-4. PubMed ID: 24949685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Response After Radiofrequency Ablation and Surgical Resection in Nonsmall Cell Lung Cancer.
    Schneider T; Hoffmann H; Dienemann H; Herpel E; Heussel CP; Enk AH; Ring S; Mahnke K
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):585-592. PubMed ID: 28043482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer.
    Grieco CA; Simon CJ; Mayo-Smith WW; DiPetrillo TA; Ready NE; Dupuy DE
    J Vasc Interv Radiol; 2006 Jul; 17(7):1117-24. PubMed ID: 16868164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
    Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
    Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.